(NASDAQ: SENS) Senseonics Holdings's forecast annual revenue growth rate of 51.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Senseonics Holdings's revenue in 2026 is $40,711,000.On average, 10 Wall Street analysts forecast SENS's revenue for 2026 to be $2,566,743,854, with the lowest SENS revenue forecast at $2,404,381,138, and the highest SENS revenue forecast at $2,712,594,399. On average, 10 Wall Street analysts forecast SENS's revenue for 2027 to be $4,070,898,141, with the lowest SENS revenue forecast at $3,405,478,544, and the highest SENS revenue forecast at $5,565,646,760.
In 2028, SENS is forecast to generate $5,950,234,038 in revenue, with the lowest revenue forecast at $4,944,872,730 and the highest revenue forecast at $6,933,439,775.